Müller WE - Search Results

1

Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase.

Albert D, Zündorf I, Dingermann T, Müller WE, Steinhilber D, Werz O. Albert D, et al. Among authors: muller we. Biochem Pharmacol. 2002 Dec 15;64(12):1767-75. doi: 10.1016/s0006-2952(02)01387-4. Biochem Pharmacol. 2002. PMID: 12445866

2

Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin.

Froestl B, Steiner B, Müller WE. Froestl B, et al. Among authors: muller we. Biochem Pharmacol. 2003 Dec 1;66(11):2177-84. doi: 10.1016/j.bcp.2003.08.010. Biochem Pharmacol. 2003. PMID: 14609742

3

Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.

Singer A, Wonnemann M, Müller WE. Singer A, et al. Among authors: muller we. J Pharmacol Exp Ther. 1999 Sep;290(3):1363-8. J Pharmacol Exp Ther. 1999. PMID: 10454515

4

Hyperforin activates nonselective cation channels (NSCCs).

Treiber K, Singer A, Henke B, Müller WE. Treiber K, et al. Among authors: muller we. Br J Pharmacol. 2005 May;145(1):75-83. doi: 10.1038/sj.bjp.0706155. Br J Pharmacol. 2005. PMID: 15723093 Free PMC article.

5

Effects of hyperforin on the fluidity of brain membranes.

Eckert GP, Müller WE. Eckert GP, et al. Among authors: muller we. Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S22-5. doi: 10.1055/s-2001-15461. Pharmacopsychiatry. 2001. PMID: 11518070

6

Hyperforin--antidepressant activity by a novel mechanism of action.

Müller WE, Singer A, Wonnemann M. Müller WE, et al. Pharmacopsychiatry. 2001 Jul;34 Suppl 1:S98-102. doi: 10.1055/s-2001-15512. Pharmacopsychiatry. 2001. PMID: 11518085

7

Hyperforin modifies neuronal membrane properties in vivo.

Eckert GP, Keller JH, Jourdan C, Karas M, Volmer DA, Schubert-Zsilavecz M, Müller WE. Eckert GP, et al. Among authors: muller we. Neurosci Lett. 2004 Sep 2;367(2):139-43. doi: 10.1016/j.neulet.2004.04.053. Neurosci Lett. 2004. PMID: 15331138

8

Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.

Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Müller WE, et al. Pharmacopsychiatry. 1998 Jun;31 Suppl 1:16-21. doi: 10.1055/s-2007-979341. Pharmacopsychiatry. 1998. PMID: 9684943

9

Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.

Leuner K, Kazanski V, Müller M, Essin K, Henke B, Gollasch M, Harteneck C, Müller WE. Leuner K, et al. Among authors: muller m, muller we. FASEB J. 2007 Dec;21(14):4101-11. doi: 10.1096/fj.07-8110com. Epub 2007 Jul 31. FASEB J. 2007. PMID: 17666455

10

Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways.

Wonnemann M, Singer A, Müller WE. Wonnemann M, et al. Among authors: muller we. Neuropsychopharmacology. 2000 Aug;23(2):188-97. doi: 10.1016/S0893-133X(00)00102-0. Neuropsychopharmacology. 2000. PMID: 10882845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,330 results

Search Page

Filters